Virulizin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVirulizin
Drug Alias NameVirulizinVirulizin-2 gamma
ClassificationNatural product/Extract > Animal extractBiologics
Mechanisms of ActionTumor necrosis factor agonistsInterleukin 17A stimulants
TargetsInterleukin 17ATumor necrosis factor
Therapy Area/IndicationsUterine Cervical NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[7] 
Global Approved IndicationsUterine Cervical NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[7] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date1997/01/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAptose
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL03A
Related LinksN/A